NN is trading 5.12% up at $3.82, with no clear company-specific announcement identified for August 11, 2026.

  • The latest material developments were NN’s August 5 second-quarter results, raised 2026 guidance, and $124 million preferred-stock refinancing, all preceding today’s move.
  • Broader markets are mixed, while healthcare is stronger; neither clearly explains NN’s gain.
  • The move may reflect trading activity or a delayed reaction, but confirmation is limited.